Magnetic-targeted carrier
Magnetic-targeted carrier (MTC) is a type of drug delivery system that uses magnetic fields to concentrate drugs or other molecules to a specific site in the body. This method is particularly useful for cancer treatment, as it allows for a higher concentration of the drug to be delivered directly to the tumor, reducing the side effects on the rest of the body.
History
The concept of MTC was first proposed in the 1970s, with the first successful in vivo experiments conducted in the 1980s. Since then, numerous studies have been conducted to improve the efficiency and safety of MTCs.
Mechanism
MTCs work by attaching magnetic nanoparticles to the drug molecules. These nanoparticles are then guided to the target site by an external magnetic field. Once at the target site, the drug is released, either by a change in the magnetic field or by the body's natural metabolic processes.
Applications
MTCs have been used in a variety of medical applications, including:
- Cancer treatment: MTCs can deliver high concentrations of chemotherapy drugs directly to tumors, reducing the side effects on the rest of the body.
- Gene therapy: MTCs can be used to deliver genes to specific cells, allowing for targeted gene therapy.
- Imaging: MTCs can be used to enhance the contrast in magnetic resonance imaging (MRI), improving the quality of the images.
Challenges
Despite their potential, MTCs face several challenges that need to be overcome before they can be widely used in clinical practice. These include:
- Biocompatibility: The magnetic nanoparticles used in MTCs need to be biocompatible to avoid causing harm to the body.
- Drug release: The release of the drug from the MTC needs to be controlled to ensure that the drug is delivered at the right time and in the right amount.
- Magnetic field: The strength and direction of the magnetic field need to be carefully controlled to ensure that the MTCs are guided to the correct location.
See also
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian



